Answers are grounded in this paper and cite their sources.
Various pharmaceuticals used for topical and systemic therapy are capable of exerting significant impact on morphological and physiological characteristics of human epidermis, as well as its barrier properties. This may affect the course of dermatologic diseases and the efficacy of their treatment. In this literature review, the author analyzes the impact of various pharmaceutical classes on the morphofunctional characteristics of the epidermal barrier and formulates recommendations for skin disease treatment.
No takes yet. Share an insight, caveat, or question.
D. D. Petrunin (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: